Pawłowska-Kamieniak Agnieszka, Krawiec Paulina, Pac-Kożuchowska Elżbieta
Department of Pediatrics and Gastroenterology, Medical University of Lublin, 20-059 Lublin, Poland.
Pediatr Rep. 2021 Feb 26;13(1):98-103. doi: 10.3390/pediatric13010014.
Acute pancreatitis (AP) appears to be rare disease in childhood. In children, it has a different aetiology and course, and requires different management than in adult patients. The diagnosis of AP is based on at least two of the three criteria, which include typical clinical symptoms, abnormalities in laboratory tests and/or imaging studies of the pancreas. There are many known causes leading to AP in children including infections, blunt abdominal trauma, genetic factors, gallstone disease, metabolic disorders, anatomical defects of the pancreas, systemic diseases, as well as drugs, including antiepileptic drugs, and especially preparations of valproic acid. In our study, we present four cases of young patients diagnosed with acute pancreatitis as a complication of valproic acid therapy and we present a review of the literature. We believe that the activity of pancreatic enzymes should be monitored in children treated with valproate preparations in the case of clinical symptoms suggesting AP.
急性胰腺炎(AP)在儿童中似乎是一种罕见疾病。在儿童中,其病因和病程有所不同,与成年患者相比,治疗方法也不同。AP的诊断基于三项标准中的至少两项,这三项标准包括典型的临床症状、实验室检查异常和/或胰腺影像学检查异常。导致儿童AP的已知原因有很多,包括感染、腹部钝性创伤、遗传因素、胆结石疾病、代谢紊乱、胰腺解剖缺陷、全身性疾病以及药物,包括抗癫痫药物,尤其是丙戊酸制剂。在我们的研究中,我们介绍了4例被诊断为丙戊酸治疗并发症的急性胰腺炎年轻患者,并对文献进行了综述。我们认为,在用丙戊酸盐制剂治疗的儿童中,如果出现提示AP的临床症状,应监测胰腺酶的活性。